A Novel Series of Synthetic Heparin-Mimetics–Itaconic Acid-Containing Copolymers for Targeting Tumor Cell Coagulability and Metastasis
Nekipelov, Katrin, Nahain, Abdullah Al, Otto, Sven, Xu, Yongbin, Li, Jin Ping, Letunica, Natasha, Collett, Simon, Attard, Chantal, Monagle, Paul, Vamvounis, George, Tsanaktsidis, John, Ferro, Vito, and Bendas, Gerd (2025) A Novel Series of Synthetic Heparin-Mimetics–Itaconic Acid-Containing Copolymers for Targeting Tumor Cell Coagulability and Metastasis. Macromolecular Bioscience, 25 (7). 2400633.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Thromboses are potentially fatal complication in malignant tumor diseases. Today, oral anticoagulants are considered equivalent alternatives to low molecular weight heparin (LMWH) in guideline-based treatments of cancer-associated thromboses. Nevertheless, debates on potential antitumorigenic heparin activities beyond anticoagulation are still highly relevant. However, disclosure of heparin targeted activities is complicated by the heterogeneous structure of this glycosaminoglycan of natural origin. Therefore, synthetic polymers appear promising as heparin mimetics to interfere with different steps in tumor metastatic spread. Here, the synthesis of noncarbohydrate copolymers of itaconic acid is described with either potassium-3-sulfopropylmethacrylate (SPMA), sodium 4-styrenesulfonate (SS), or 2-acrylamido-2-methyl-1-propanesulfonate (AMPS) via reversible addition-fragmentation-chain-transfer (RAFT) polymerization. The copolymers, characterized by GPC, display high efficiencies to inhibit heparanase enzymatic activity, exceeding the potency of the clinical candidate PG545. The SS-copolymers (poly(SS-co-IA)) outperform the other copolymers and LMWH in blocking tumor cell-induced platelet activation (TCIPA), thus platelet degranulation or aggregation as key issues in metastasis by reducing thrombin formation. The cytotoxicity of poly(SS-co-IA) is very low. Notably, poly(SS-co-IA) copolymers displayed a thousand-fold lower binding affinity to platelet factor-4 (PF4) than unfractionated heparin (UFH), suggesting a lower risk for HIT II susceptibility. The indicated polymers represent promising heparin mimetics with superior activities in oncology for metastatic control.
| Item ID: | 87937 |
|---|---|
| Item Type: | Article (Research - C1) |
| ISSN: | 1616-5195 |
| Keywords: | cancer, coagulation, heparanase, heparin mimetics, metastasis, PF-4, platelets |
| Copyright Information: | © 2025 The Author(s). Macromolecular Bioscience published by Wiley-VCH GmbH This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| Date Deposited: | 16 Mar 2026 00:30 |
| FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3205 Medical biochemistry and metabolomics > 320503 Medical biochemistry - inorganic elements and compounds @ 100% |
| SEO Codes: | 20 HEALTH > 2001 Clinical health > 200105 Treatment of human diseases and conditions @ 100% |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |